WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1996005195) NOVEL N-SUBSTITUTED NAPHTHOFUSED LACTAMS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1996/005195    International Application No.:    PCT/DK1995/000332
Publication Date: 22.02.1996 International Filing Date: 17.08.1995
Chapter 2 Demand Filed:    13.03.1996    
IPC:
C07D 223/14 (2006.01), C07D 403/10 (2006.01), C07D 413/14 (2006.01)
Applicants: NOVO NORDISK A/S [DK/DK]; Novo Allé, DK-2880 Bagsværd (DK) (For All Designated States Except US).
THØGERSEN, Henning [DK/DK]; (DK) (For US Only).
HANSEN, Birgit, Sehested [DK/DK]; (DK) (For US Only).
PESCHKE, Bernd [DK/DK]; (DK) (For US Only).
HANSEN, Thomas, Kruse [DK/DK]; (DK) (For US Only).
ANDERSEN, Knud, Erik [DK/DK]; (DK) (For US Only)
Inventors: THØGERSEN, Henning; (DK).
HANSEN, Birgit, Sehested; (DK).
PESCHKE, Bernd; (DK).
HANSEN, Thomas, Kruse; (DK).
ANDERSEN, Knud, Erik; (DK)
Common
Representative:
NOVO NORDISK A/S; att.: Marianne Larsen, Corporate Patents, Novo Allé, DK-2880 Bagsvaerd (DK)
Priority Data:
0952/94 17.08.1994 DK
Title (EN) NOVEL N-SUBSTITUTED NAPHTHOFUSED LACTAMS
(FR) NOUVEAUX LACTAMES NAPHTOFUSIONNES A SUBSTITUTION N
Abstract: front page image
(EN)Disclosed are novel N-substituted naphthofused lactams and salts thereof of formula (I). Compounds of general formula (I) possess the ability to stimulate the release of endogenous growth hormone. Thus, these compounds may be used in the treatment of conditions which require stimulation of growth hormone production or secretion such as in humans with growth hormone deficiency or where increased growth hormone plasma levels are desired, for instance in elderly patients or in livestock.
(FR)L'invention concerne de nouveaux lactames naphtofusionnés à substitution N ainsi que leurs sels de formule (I). Les composés de formule (I) présentent la capacité de stimuler la libération de l'hormone de croissance endogène. Ainsi, on peut utiliser ces composés dans le traitement d'états nécessitant une stimulation de la production ou de la sécrétion de l'hormone de croissance tels que chez des individus présentant une carence en hormone de croissance ou lorsque l'on veut augmenter les niveaux d'hormone de croissance dans le plasma, par exemple chez des patients agés ou chez des animaux d'élevage.
Designated States: AM, AU, BB, BG, BR, BY, CA, CN, CZ, EE, FI, GE, HU, IS, JP, KG, KP, KR, KZ, LK, LR, LT, LV, MD, MG, MN, MX, NO, NZ, PL, RO, RU, SG, SI, SK, TJ, TM, TT, UA, US, UZ, VN.
African Regional Intellectual Property Organization (KE, MW, SD, SZ, UG)
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)